Nasdaq smmt.

Cambridge, MA, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced topline results for the Phase III Ri-CoDIFy study ...WebCambridge, MA, June 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual ...Oxford, UK, and Cambridge, MA, US, September 17, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) led by billionaire investor Robert W. Duggan as Executive Chairman, Chief Executive Officer and ...WebOxford, UK, and Cambridge, MA, US, 9 July 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announces that it has demonstrated the potential of its DDS-04 series of new class ...Nov 22, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.

Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit Therapeutics (NASDAQ:SMMT) is a project of Bob Duggan of Pharmacyclics fame. This is what keeps our hopes in the future of this company alive, even though the company keeps changing so much ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebTitle. Nov 27, Insiders hold 82% of Summit Therapeutics Inc. (NASDAQ:SMMT), and they've been buying recently. Nov 8, Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 ...MENLO PARK, Calif., October 31, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that data for its novel, potential first-in-class investigational bispecific antibody, ivonescimab, will be presented at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in San Diego, CA.Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.WebSummit Therapeutics Inc. Common Stock (SMMT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

Nov 16, 2023 · The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97.

Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...(NASDAQ:SMMT) insiders must be dismayed to see the company's market cap drop to US$1.2b. (Simply Wall St.) May-16-23 01:21PM · Why Shares of Summit ...Nov 8, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. Oxford, UK, and Cambridge, MA, US, April 30, 2020 - Summit Therapeutics plc (NASDAQ: SMMT) today reports its financial results for the fourth period * and eleven months ended December 31, 2019 ...OXFORD, United Kingdom, Sept. 24, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Phunware Inc (NASDAQ:PHUN)’s Major holders Insiders own 8.46% of the company shares, while shares held by institutions stand at 9.60% with a share float percentage of 10.48%. Investors are also buoyed by the number of investors in a company, with Phunware Inc having a total of 43 institutions that hold shares in the company.

78% of the company is held by a single shareholder (Robert Duggan) Insiders have been buying lately. If you want to know who really controls Summit Therapeutics Inc. ( NASDAQ:SMMT ), then you'll ...WebSummit Therapeutics Inc. Common Stock (SMMT) Analyst Research | Nasdaq in the last 3 months. The average price target is Sign in to your SmartPortfolio to see more analyst …Summit Therapeutics Inc. (NASDAQ:SMMT) Short Interest Up 2,045.6% in December marketbeat.com - December 28 at 1:08 PM: Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week finance.yahoo.com - December 9 at 2:06 PM: marketbeat.com - December 9 at 10:28 AMNASDAQ: SMMT. 2.13USD 0.10. At 04/12/2023 11:30. More information SEC Filings. Current report filing. VIEW FILING. Quarterly report pursuant to sections 13 or 15(d) VIEW FILING More information Analyst Coverage Visit …OXFORD, United Kingdom, Sept. 27, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...

11 de mai. de 2023 ... (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the ...Oxford, UK, and Cambridge, MA, US, 17 December 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today announces that Erik Ostrowski will ...

Nov 8, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. 2 de nov. de 2023 ... (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Laura Chow, MD, has joined Summit Therapeutics as Senior Vice ...Summit Therapeutics Inc (NASDAQ:SMMT) trade information. Sporting 7.07% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, 11/14/23 when the SMMT stock price touched $1.97 or saw a rise of 0.51%.OXFORD, United Kingdom, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces further positive findings from PhaseOut DMD, a Phase 2 open-label, multi-centre ...Summit Therapeutics Inc (NASDAQ:SMMT) announced that the FDA disagrees with its proposed change to the primary endpoint in Phase 3 Ri-CoDIFy studies.; In a regulatory filing, the Company said that ...What were the latest earnings per share (EPS) for Summit Therapeutics (NASDAQ:SMMT)? A. Summit Therapeutics ( SMMT) does not have any upcoming earnings reports scheduled yet. The last reported ...OXFORD, United Kingdom, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...

Find the latest news headlines from Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com.

Jun 29, 2023 · Investors eyeing a purchase of Summit Therapeutics Inc (Symbol: SMMT) stock, but cautious about paying the going market price of $2.52/share, might benefit from considering selling puts among the ...

OXFORD, United Kingdom, Sept. 27, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Oxford, UK, and Cambridge, MA, US, September 17, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) led by billionaire investor Robert W. Duggan as Executive Chairman, Chief Executive Officer and ...WebMENLO PARK, Calif., January 30, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") today announced that the Company’s Board of Directors has set the record date for the ...WebSource: Kantar Media. View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ.Find the latest Insider Activity data for Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com. The Society of Motor Manufacturers & Traders (SMMT) supports and promotes the interests of the UK automotive industry at home and abroad.Jan 30, 2023 · MENLO PARK, Calif., January 30, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") today announced that the Company’s Board of Directors has set the record date for the ... Phunware Inc (NASDAQ:PHUN) has a beta value of 10.36 and has seen 4.58 million shares traded in the recent trading session. The company, currently valued at $19.34M, closed the recent trade at $0.14 per share which meant it gained $0.01 on the day or 13.69% during that session. The PHUN stock price ...WebFor the three months ended September 30th, 2018 vs September 30th, 2017, Global Payments reported revenue of $857.67MM vs $1,038.91MM (down 17.44%) and analysts estimated basic earnings per share ...WebOXFORD, United Kingdom, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...May 11, 2022 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...

View live Summit Therapeutics Inc. chart to track its stock's price action. Find market predictions, SMMT financials and market news.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.What were the latest earnings per share (EPS) for Summit Therapeutics (NASDAQ:SMMT)? A. Summit Therapeutics ( SMMT) does not have any upcoming earnings reports scheduled yet. The last reported ...Instagram:https://instagram. nvda dividend dateaes corpvanguard lifestrategy moderate growth fundtruist trade 3 de fev. de 2023 ... Summit Therapeutics (NASDAQ:SMMT) shares are plummeting over 40% on Friday morning. Gaucho Group Holdings (NASDAQ:VINO) stock is diving more ... canopy growth stock forecast 2025moomoo financial reviews OXFORD, England, Aug. 17, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ...Oxford, UK, and Cambridge, MA, US, September 17, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) led by billionaire investor Robert W. Duggan as Executive Chairman, Chief Executive Officer and ...Web american funds europacific growth fund r6 OXFORD, United Kingdom, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...CAMBRIDGE, Mass. and OXFORD, United Kingdom, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for ...WebNov 8, 2023 · The public float for SMMT is 111.75M, and currently, short sellers hold a 9.57% ratio of that floaft. The average trading volume of SMMT on November 08, 2023 was 1.02M shares. SMMT) stock’s latest price update. Summit Therapeutics Inc (NASDAQ: SMMT)’s stock price has plunge by -12.16relation to previous closing price of 2.18.